What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Heart failure
The scientist’s investigation covers issues in Internal medicine, Cardiology, Heart failure, Hypertrophic cardiomyopathy and Cardiomyopathy.
The concepts of his Internal medicine study are interwoven with issues in Guideline and Surgery.
As part of his studies on Cardiology, James E. Udelson often connects relevant subjects like Magnetic resonance imaging.
His Heart failure research incorporates elements of Endocrinology, Afterload and Vasopressin Antagonists.
His work on Ventricular outflow tract obstruction as part of general Hypertrophic cardiomyopathy study is frequently linked to Septal myectomy, Alcohol septal ablation and Ventricular Outflow Obstruction, therefore connecting diverse disciplines of science.
His Cardiomyopathy research is multidisciplinary, relying on both Basal, Prospective cohort study, Circulatory system, Anterior mitral leaflet and Cohort.
His most cited work include:
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (1595 citations)
- Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial (1252 citations)
- ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) (1220 citations)
What are the main themes of his work throughout his whole career to date?
James E. Udelson spends much of his time researching Internal medicine, Cardiology, Heart failure, Ejection fraction and Coronary artery disease.
His work on Hypertrophic cardiomyopathy, Myocardial infarction, Randomized controlled trial and Heart disease is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science.
His research in Cardiology intersects with topics in Magnetic resonance imaging and Radiology.
His Heart failure study combines topics from a wide range of disciplines, such as Placebo, Clinical trial, Vasopressin Antagonists and Intensive care medicine.
His Ejection fraction study integrates concerns from other disciplines, such as Asymptomatic and Heart rate.
His Coronary artery disease study incorporates themes from Framingham Risk Score, Perfusion and Revascularization.
He most often published in these fields:
- Internal medicine (70.73%)
- Cardiology (65.17%)
- Heart failure (40.17%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (70.73%)
- Cardiology (65.17%)
- Heart failure (40.17%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Cardiology, Heart failure, Chest pain and In patient.
Myocardial infarction, Coronary artery disease, Randomized controlled trial, Acute coronary syndrome and Hypertrophic cardiomyopathy are among the areas of Internal medicine where James E. Udelson concentrates his study.
His work in the fields of Coronary artery disease, such as Myocardial perfusion imaging, intersects with other areas such as CAD.
His study in Cardiology is interdisciplinary in nature, drawing from both Therapeutic effect, Cardiac magnetic resonance imaging and Hazard ratio.
His biological study spans a wide range of topics, including Anesthesia, Clinical trial and Intensive care medicine.
His Chest pain research is multidisciplinary, incorporating perspectives in Imaging study, Radiology, Cohort and Functional testing.
Between 2015 and 2021, his most popular works were:
- Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials (219 citations)
- Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). (169 citations)
- Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial. (119 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Myocardial infarction
James E. Udelson mainly focuses on Internal medicine, Cardiology, Heart failure, Myocardial infarction and Chest pain.
His Internal medicine research focuses on Coronary artery disease, Randomized controlled trial, Prospective cohort study, Hypertrophic cardiomyopathy and Obstructive hypertrophic cardiomyopathy.
In general Cardiology study, his work on Acute coronary syndrome often relates to the realm of In patient, thereby connecting several areas of interest.
His work deals with themes such as Mitral valve, Clinical endpoint and Quality of life, which intersect with Heart failure.
The study incorporates disciplines such as Ventricle and Hemodynamics in addition to Myocardial infarction.
The various areas that James E. Udelson examines in his Chest pain study include Coronary computed tomography angiography and Radiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
